1999-2019年非西班牙裔美国印第安/阿拉斯加原住民侵袭性皮肤黑色素瘤发病率分析
该研究基于美国癌症统计AI/AN发病分析数据库与印第安卫生服务行政数据库链接数据,分析1999-2019年15岁及以上非西班牙裔美国印第安/阿拉斯加原住民侵袭性皮肤黑色素瘤发病率与趋势。共2151例(女性47.5%),总发病率10.7/10万(95%CI 10.3-11.2),男性高于女性,55岁及以上更高。女性、区域/远处分期肿瘤及55岁及以上人群发病率随时间上升。
要点
- 非西班牙裔AI/AN人群侵袭性皮肤黑色素瘤总发病率为10.7/10万(95%CI 10.3-11.2)。
- 男性发病率13.0/10万高于女性9.2/10万,55岁及以上24.2/10万高于15-39岁3.5/10万。
- 1999-2019年女性(AAPC 2.5,P<.001)、区域/远处分期(AAPC 2.5,P=.01)及55岁及以上(AAPC 2.8,P=.001)发病率上升。
核心结论
- 非西班牙裔AI/AN人群侵袭性皮肤黑色素瘤发病率存在性别、年龄和地区差异,且女性、晚期肿瘤及55岁及以上人群发病率呈上升趋势。
研究设计与样本
- 描述性观察性横断面研究,使用美国癌症统计AI/AN发病分析数据库链接印第安卫生服务行政数据库,纳入1999-2019年15岁及以上联邦认可部落成员且居住于IHS购买/转诊服务区的非西班牙裔AI/AN侵袭性皮肤黑色素瘤患者,数据于2022年分析。
主要发现
- 1999-2019年共2151例非西班牙裔AI/AN侵袭性皮肤黑色素瘤患者,女性1021例(47.5%),总发病率10.7/10万(95%CI 10.3-11.2)。
- 男性发病率13.0/10万(95%CI 12.2-13.8)高于女性9.2/10万(95%CI 8.6-9.8)。
- 55岁及以上发病率24.2/10万(95%CI 22.8-25.7)高于15-39岁3.5/10万(95%CI 3.2-3.9);男性55岁及以上最高34.5/10万(95%CI 31.8-37.3)。
- 南方平原地区男性发病率23.8/10万(95%CI 21.5-26.2)、女性15.5/10万(95%CI 14.0-17.2);太平洋沿岸地区男性16.5/10万(95%CI 14.5-18.7)、女性12.3/10万(95%CI 10.9-13.9)。
- 1999-2019年女性发病率年均百分比变化(AAPC)2.5(P<.001),区域/远处分期肿瘤AAPC 2.5(P=.01),55岁及以上人群AAPC 2.8(P=.001)。
临床怎么用
- 皮肤科医生应关注非西班牙裔AI/AN人群的侵袭性皮肤黑色素瘤风险,尤其是男性、55岁及以上及南方平原和太平洋沿岸地区人群。
- 对女性和55岁及以上非西班牙裔AI/AN人群,需警惕发病率上升趋势,加强早期筛查与监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Non-Hispanic American Indian/Alaska Native people have the second highest incidence rate of invasive cutaneous melanoma in the US after non-Hispanic White people. OBJECTIVE: To examine invasive cutaneous melanoma incidence rates and trends over time among non-Hispanic American Indian/Alaska Native people. DESIGN, SETTING, AND PARTICIPANTS: This descriptive, observational cross-sectional study used population-based cancer registry data (US Cancer Statistics AI/AN Incidence Analytic Database) linked to the Indian Health Service administrative database to examine incidence rates by age, sex, region, histology, tumor site, stage, and other demographic and clinical characteristics. The study examined trends from 1999 to 2019 time period by age, sex, stage at diagnosis, and region. Non-Hispanic American Indian/Alaska Native people 15 years and older who received a diagnosis of invasive cutaneous melanoma from 1999 to 2019 who were members of federally recognized tribes and resided in Indian Health Service purchased/referred care delivery areas were included in this study to reduce racial misclassification and provide more accurate rates. The data were analyzed in 2022. EXPOSURES: Demographic and clinical characteristics, such as age, sex, geographic region, histology, stage, and tumor site. MAIN OUTCOMES AND MEASURES: Invasive cutaneous melanoma incidence rates by age group, sex, region, resident county characteristics (poverty level, rurality, education level, and socioeconomic status), stage at diagnosis, tumor site, and histology. Trends over time by age, sex, region, and stage. RESULTS: From 1999 to 2019, 2151 non-Hispanic American Indian/Alaska Native people (1021 female individuals [47.5%]) received a diagnosis of incident cutaneous melanoma (rate, 10.7 per 100 000; 95% CI, 10.3-11.2). Rates were higher among male than female individuals (13.0 [95% CI, 12.2-13.8] vs 9.2 [95% CI, 8.6-9.8]) and for people 55 years and older (24.2; 95% CI, 22.8-25.7) compared with those aged 15 to 39 years (3.5; 95% CI, 3.2-3.9). Rates were highest for male individuals 55 years and older (34.5; 95% CI, 31.8-37.3) and people living in the Southern Plains (male individuals: 23.8; 95% CI, 21.5-26.2; female individuals: 15.5; 95% CI, 14.0-17.2) and Pacific Coast region (male individuals: 16.5; 95% CI, 14.5-18.7; female individuals: 12.3; 95% CI, 10.9-13.9). Rates increased among female individuals from 1999 to 2019 (average annual percent change [AAPC], 2.5; P < .001); among regional/distant stage tumors (AAPC, 2.5; P = .01) and people 55 years and older (AAPC, 2.8; P = .001). CONCLUSIONS AND RELEVANCE: The results of this study suggest that additional studies could potentially identify risk factors among non-Hispanic American Indian/Alaska Native people.
引用
- Townsend JS, Melkonian SC, Jim MA, et al. Melanoma Incidence Rates Among Non-Hispanic American Indian/Alaska Native Individuals, 1999-2019. JAMA Dermatol. 2024. PMID: 38150212. doi:10.1001/jamadermatol.2023.5226
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。